Loading live market data…

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$38.17 USD

-$0.36 (-0.93%)

Volume
702.07K
Average Volume
959.49K
Market Capitalization
$2.54B
P/E Ratio
-8.94
Dividend Yield
0.00%
Price Target
$48.00
Year High
$40.30
Year Low
$19.72
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$8.92

CLDX Estimated and Actual Revenue by Quarter

CLDX Estimated and Actual EPS by Quarter

CLDX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -1.42M -340.64K -880K -1.42M -340.64K -880K
2027-09-30 3 -1.42M -340.64K -880K -1.42M -340.64K -880K
2027-06-30 3 -1.42M -340.64K -880K -1.42M -340.64K -880K
2027-03-31 3 -1.42M -340.64K -880K -1.42M -340.64K -880K
2026-12-31 5 -1.64M -394.48K -1.02M -1.64M -394.48K -1.02M
2026-09-30 6 -1.3M -310.94K -803.25K -1.3M -310.94K -803.25K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -133.16M -15.06M -74.11M 3.76M 15.65M 9.7M
2027-09-30 3 -123.59M -13.98M -68.78M 3.76M 15.65M 9.7M
2027-06-30 3 -116.02M -13.12M -64.57M 3.76M 15.65M 9.7M
2027-03-31 3 -113.62M -12.85M -63.24M 3.76M 15.65M 9.7M
2026-12-31 5 -127.67M -14.44M -71.06M 4.35M 18.12M 11.24M
2026-09-30 6 -74.76M -69.42M -71.42M 3.43M 14.28M 8.86M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 340.64K 1.42M 880K 2 -2.0004 -0.22626 -1.11333
2027-09-30 3 340.64K 1.42M 880K 2 -1.85666 -0.21 -1.03333
2027-06-30 3 340.64K 1.42M 880K 2 -1.74287 -0.19713 -0.97
2027-03-31 3 340.64K 1.42M 880K 3 -1.70694 -0.19306 -0.95
2026-12-31 5 394.48K 1.64M 1.02M 3 -1.918 -0.21694 -1.06747
2026-09-30 6 310.94K 1.3M 803.25K 7 -1.12308 -1.04286 -1.07294